Dendritic cell activation by danger and antigen-specific T-cell signalling

Experimental Dermatology

Volumn 9, Issue 5, 2000, Pages 313-322

  McLellan, A D ^a   Brocker E B ^a   Kampgen E ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Activation; Costimulation; Danger; Dendritic cell; Tolerance

Indexed keywords

B LYMPHOCYTE ANTIBODY; CD8 ANTIGEN; DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYALURONIC ACID; INTERLEUKIN 1; INTERLEUKIN 10; RNA; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; CELL ACTIVATION; CELL COMMUNICATION; CELLULAR IMMUNITY; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; WOUND HEALING;

DENDRITIC CELLS; EPITOPES; ESCAPE REACTION; HUMANS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0033832491     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2000.009005313.x     Document Type: Review

References (99)

1. Dendritic cells: Unique leukocyte populations which control the primary immune response
2. Dendritic cells and the control of immunity
3. A theory of self-nonself discrimination
4. The two-signal model of lymphocyte activation twenty-one years later
5. The immune system evolved to discriminate infectious nonself from noninfectious self
6. Tolerance, danger, and the extended family
7. Cell interactions and cytokines in transplantation immunity
8. The 'injury response': A concept linking nonspecific injury, acute rejection, and long-term transplant outcomes
9. Natural adjuvants: Endogenous activators of dendritic cells
10. Consequences of cell death. Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
11. Activation of human dendritic cells through CD40 cross-linking
12. T cell-dependent secretion of IL-1 beta by a dendritic cell line (XS52) derived from murine epidermis
13. Human dendritic cells activate T lymphocytes via a CD40:CD40 ligand-dependent pathway
14. + T-helper and a T-killer cell
15. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
16. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
17. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation
18. Induction of dendritic cell costimulator molecule expression is suppressed by T cells in the absence of antigen specific signalling: Role of cluster formation, CD40 and HLA-class II for dendritic cell activation
19. Dendritic cells need T cell help to prime cytotoxic T cell responses to strong antigens
20. A new analysis of allogeneic interactions
21. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo
22. Dual function of Drosophila cells as APCs for naive CD8+ T cells: Implications for tumor immunotherapy
23. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro
24. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations
25. The tissue distribution of the B7-2 costimulator in mice: Abundant expression on dendritic cells in situ and during maturation in vitro
26. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule
27. Functional expression of CD40 antigen on human epidermal Langerhans cells
28. Migration and maturation of Langerhans cells in skin transplants and explants
29. Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model
30. Reply from Ephraim Fuchs
31. A fail-safe mechanism for maintaining self-tolerance
32. Danger - Pathogen on the premises! Immunological tolerance
33. The instructive role of innate immunity in the acquired immune response
34. Coordinated events during bacteria-induced DC maturation
35. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype
36. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance
37. Other functions, other genes: Alternative activation of antigen-presenting cells
38. CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection
39. TNF alpha interrupts antigen-presenting function of Langerhans cells by two mechanisms: Loss of immunogenic peptides and impairment of antigen-independent T-cell clustering
40. Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation
41. CD11b+ macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein
42. Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing
43. Interleukin 1 enhances T-dependent immune responses by amplifying the function of dendritic cells
44. Adhesive and/or signaling functions of CD44 isoforms in human dendritic cells
45. Depletion of epidermal Langerhans cells and Ia immunogenicity from tape-stripped mouse skin
46. Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration
47. Keratinocytes: Key immunocytes of the integument
48. Distribution of HLA class II molecules in epidermal Langerhans cells in situ
49. Dendritic cells from mouse bone marrow: In vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor
50. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
51. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow
52. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures
53. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70
54. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides
55. A peptide binding protein having a role in antigen presentation is a member of the HSP70 heat shock family
56. Human 60-kDa heat-shock protein: A danger signal to the innate immune system
57. Cutting edge: Heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells
58. Morphostasis: An evolving perspective
59. Gap junctions: A novel route for direct cell-cell communication in the immune system?
60. Connexins: A connection with the skin
61. Is cancer dangerous to the immune system?
62. T cell defined tumor antigens
63. Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic energy
64. Constitutive expression of B7-1 (CD80) on mouse keratinocytes does not prevent development of chemically induced skin papillomas and carcinomas
65. Tumour immunology: Alternative perspectives
66. Terra firma: A retreat from 'danger'
67. Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes
68. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion
69. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells
70. Functions of myeloid and lymphoid dendritic cells
71. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis
72. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes
73. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1
74. Dermal dendritic cells associated with T lymphocytes in normal human skin display an activated phenotype
75. Control of immune pathology by regulatory T cells
76. T-cell specificity for H-2 and Ir gene phenotype correlates with the phenotype of thymic antigen-presenting cells
77. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo
78. T lymphocyte tolerance: From thymic deletion to peripheral control mechanisms
79. Does T-cell tolerance require a dedicated antigen-presenting cell?
80. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen
81. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
82. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
83. High-level IL-12 production by human dendritic cells requires two signals
84. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor
85. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells
86. Induction of costimulatory molecule B7 in M12 B lymphomas by cAMP or MHC-restricted T cell interaction
87. Induction, regulation, and function of soluble TRAP (CD40 ligand) during interaction of primary CD4+ CD45RA+ T cells with dendritic cells
88. Altered CD40 ligand induction in tolerant T lymphocytes
89. Ligation of major histocompatibility complex class II molecules mediates apoptotic cell death in resting B lymphocytes
90. Triggering HLA-DR molecules on human peripheral monocytes induces their death
91. Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development
92. Turnover of naive- and memory-phenotype T cells
93. Viral induction of co-stimulatory activity on antigen-presenting cells bypasses the need for CD4+ T-cell help in CD8+ T-cell responses
94. CD40-ligated dendritic cells effectively expand melanoma specific CD8+ CTLs and CD4+ IFN-gamma producing T cells from tumour infiltrating lymphocytes
95. The specific direct interaction of helper T cells and antigen-presenting B cells
96. Physical interaction between Langerhans cells and T-lymphocytes during antigen presentation in vitro
97. Expression and function of B7 on human epidermal Langerhans cells
98. MHC class II and CD40 play opposing roles in dendritic cell survival